Table 5. Combination Index Values of Afatinib When Combined With Palbociclib, Dinaciclib, Capmatinib, Dasatinib, Stattic, Ponatinib, AZD4547, Trametinib, Miransertib, Paclitaxel in Human Stomach Cancer Cell Lines.

	Combination index (CI)
	AGS		MKN1		NCI-N87
TKI combination	FBS 2%	FBS 10%	FBS 2%	FBS 10%	FBS 2%	FBS 10%
Afatinib + palbociclib	0.36	1.02	0.38	1.89	1.07	1.31
Afatinib + dinaciclib	0.95	1.08	0.42	0.53	1.58	2.23
Afatinib + capmatinib	0.62	0.85	0.24	0.48	1.55	1.28
Afatinib+ dasatinib	0.48	0.46	0.37	0.23	1.02	0.90
Afatinib + stattic	0.87	0.86	0.87	0.68	1.06	2.60
Afatinib+ ponatinib	2.51	1.23	0.45	0.43	2.63	1.19
Afatinib + AZD4547	1.32	1.60	0.20	1.14	1.69	1.14
Afatinib+ trametinib	0.37	1.11	0.40	1.16	1.22	0.8
Afatinib + miransertib	0.60	0.82	0.26	0.16	0.76	0.71
Afatinib + paclitaxel	0.07	1.20	1.33	0.41	1.64	2.04

TKI: tyrosine kinase inhibitor; FBS: fetal bovine serum.